Publications & Posters

Posters

Leveraging PM21-NK Cells in IO Combinations for Treatment of Solid Tumors
PEGS Boston, September 2020

file image

2020 EBMT Virtual Annual Meeting
29Aug2020 e-Poster: Phase I Study of Adoptive Transfer of Haploidentical Expanded NK Cells

file image

2020 ASGCT Virtual Annual Meeting
12May2020 Poster Presentation Abstract 765: NK Cell Expansion and Phenotype Shaping Using CD16-targeted CSTX002-Fc Feeder Cells

file image

2020 ASGCT Virtual Annual Meeting
12May2020 Poster Presentation Abstract 427: Bridging NK cell expansion methods towards a feeder-cell free scalable GMP production of hyperfunctional NK cells

file image

2020 ASGCT Virtual Annual Meeting
12May2020 Video: Bridging NK cell expansion methods towards a feeder-cell free scalable GMP production of hyperfunctional NK cells

file image

ISCT 2020 Virtual Meeting
28May2020 Poster Presentation Abstract 228: Cytokine pre-activation enhances PM21-particle driven NK cell expansion

file image

ASCO 2020 Virtual Annual Meeting
29May2020 Poster Presentation Abstract 3025: CD56bright/CD16bright FC21-NK-cell adoptive immunotherapy in patients with concurrent CNS disease and relapsed or refractory (R/R) AML

file image

ASCO 2020 Virtual Annual Meeting
29May2020 Abstract TPS7562: Abstract TPS7562: A Phase I Clinical Trial Testing the Safety of IL-21-Expanded, Off-the-Shelf, Natural Killer Cells for Relapsed/Refractory Acute Myeloid Leukemia

file image

ASCO 2020 Virtual Annual Meeting
Abstract e15018: Impact of CD38 knockout in NK cells on daratumumab-mediated cytotoxicity and cellular metabolism

file image

25th Congress of the European Hematology Association
12Jun2020 Abstract S284: Early-phase Clinical Trials of Adoptive Transfer of Hyperfunctional NK Cells Expanded Ex Vivo with IL-21 Demonstrate Functional, Phenotypic, and Haplotype-specific evidence of in vivo persistence

file image

25th Congress of the European Hematology Association
12Jun2020 Abstract EP1487: Deep functional and phenotypic characterization* of expanded and cryopreserved NK cells establishes consistent product identity across GMP and clinical-scale manufacturing sites and FC21 and PM21 platforms as intended for clinical use

file image

25th Congress of the European Hematology Association
12Jun2020 Abstract EP58: Clinical and radiological resolution of infections during treatment with mbIL-21-expanded FC21-NK cells in patients with relapsed or refractory acute myeloid leukaemia (R/R AML)

file image